Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
The Fly
Roche announces results from phase I/II data on NXT007
14d ago
CHRO
Premium
The Fly
Lineage Cell Therapeutics announces RG6501 study meets primary endpoint at CTS
14d ago
CHRO
LCTX
Premium
The Fly
Roche says Lunsumio-Polivy combo significantly prolongs remission in study
17d ago
CHRO
Premium
The Fly
Genentech reports 11.5 months progression-free survival in SUNMO study
17d ago
CHRO
Premium
The Fly
MAIA Biotechnology, Roche sign supply agreement for cancer therapies
20d ago
CHRO
MAIA
Premium
The Fly
Trump administration weighs crackdown on pharma ads, Bloomberg says
21d ago
AZN
BMY
Premium
The Fly
Roche, AbbVie say Phase III VERONA study faliled in MDS
21d ago
ABBV
CHRO
Premium
The Fly
Roche, AbbVie says Phase III VERONA study faliled in MDS
21d ago
ABBV
CHRO
Premium
The Fly
Prothena partner Roche advances prasinezumab into Phase 3
22d ago
CHRO
PRTA
Premium
The Fly
Genentech to proceed with Phase III development of prasinezumab
22d ago
CHRO
Premium
The Fly
Senators to propose ban on drug ads to consumers, WSJ reports
25d ago
AZN
BMY
Premium
The Fly
Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz
25d ago
BA
GE
Premium
The Fly
Roche CEO says Trump’s drug pricing order threatens investment, WSJ reports
26d ago
CHRO
Premium
The Fly
RFK Jr. names eight members to vaccine panel, WSJ reports
26d ago
AZN
BMY
Premium
The Fly
RFK Jr. names new CDC vaccine advisory panel picks, STAT reports
26d ago
AZN
BMY
Premium
The Fly
Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
28d ago
AZN
BMY
Premium
The Fly
RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members
28d ago
AZN
BMY
Premium
The Fly
RFK Jr. removes members of vaccine-advising CDC panel, CNBC reports
28d ago
AZN
BMY
Premium
The Fly
Vaccine opponent hired by RFK Jr. searches CDC record for autism link, WSJ says
1M ago
AZN
BMY
Premium
The Fly
Rapt Therapeutics started at Buy at Clear Street on RPT904b opportunity
1M ago
NVS
CHRO
Premium
The Fly
Roche’s Evrysdi tablet approved by EC for SMA
1M ago
CHRO
Premium
The Fly
Genentech reports ‘positive’ results from Phase III IMforte study
1M ago
CHRO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
